Literature DB >> 26133903

Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.

Ayse L Mindikoglu1, Thomas C Dowling2, Laurence S Magder3, Robert H Christenson4, Matthew R Weir5, Stephen L Seliger5, William R Hutson6, Charles D Howell7.   

Abstract

BACKGROUND & AIMS: Equations used to estimate glomerular filtration rate (GFR) are not accurate in patients with cirrhosis. We aimed to develop a new equation to estimate the GFR in subjects with cirrhosis and compare its performance with chronic kidney disease epidemiology collaboration (CKD-EPI) cystatin C and creatinine-cystatin C equations, which were derived in populations without cirrhosis.
METHODS: From 2010 through 2014, we measured GFR in 103 subjects with cirrhosis based on non-radiolabeled iothalamate plasma clearance. We measured blood levels of creatinine, cystatin C, β-trace protein, β2-microglobulin, L-arginine, and symmetric and asymmetric dimethylarginines simultaneously with GFR. Multivariate linear regression analysis was performed to develop models to estimate GFR. Overall accuracy, defined by the root mean square error (RMSE) of our newly developed model to estimate GFR, was compared with that of the CKD-EPI equations. To obtain an unbiased estimate of our new equation to estimate GFR, we used a leave-one-out cross-validation strategy.
RESULTS: After we considered all the candidate variables and blood markers of GFR, the most accurate equation we identified to estimate GFR included serum levels of creatinine and cystatin C, as well as patients' age, sex, and race. Overall, the accuracy of this equation (RMSE = 22.92) was superior to that of the CKD-EPI cystatin C equation (RMSE = 27.27, P = .004). Among subjects with cirrhosis and diuretic-refractory ascites, the accuracy of the equation we developed to estimate GFR (RMSE = 19.36) was greater than that of the CKD-EPI cystatin C (RMSE = 27.30, P = .003) and CKD-EPI creatinine-cystatin C equations (RMSE = 23.37, P = .004).
CONCLUSIONS: We developed an equation that estimates GFR in subjects with cirrhosis and diuretic-refractory ascites with greater accuracy than the CKD-EPI cystatin C equation or CKD-EPI creatinine-cystatin C equation.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic; End-stage Liver Disease; Liver Transplantation; Prognostic Factor

Mesh:

Substances:

Year:  2015        PMID: 26133903      PMCID: PMC4695320          DOI: 10.1016/j.cgh.2015.06.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  40 in total

1.  Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations.

Authors:  Thomas A Gonwa; Linda Jennings; Martin L Mai; Paul C Stark; Andrew S Levey; Goran B Klintmalm
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Gender disparity in liver transplant waiting-list mortality: the importance of kidney function.

Authors:  Ayse L Mindikoglu; Arie Regev; Stephen L Seliger; Laurence S Magder
Journal:  Liver Transpl       Date:  2010-10       Impact factor: 5.799

4.  Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.

Authors:  Michiel P C Siroen; Reiner Wiest; Milan C Richir; Tom Teerlink; Jan A Rauwerda; Friedrich T Drescher; Niels Zorger; Paul A M van Leeuwen
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

5.  The human liver clears both asymmetric and symmetric dimethylarginine.

Authors:  Michiel P C Siroen; Joost R M van der Sijp; Tom Teerlink; Cors van Schaik; Robert J Nijveldt; Paul A M van Leeuwen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study.

Authors:  M A Papadakis; A I Arieff
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

7.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

8.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

9.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

10.  Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance.

Authors:  D M Cocchetto; C Tschanz; T D Bjornsson
Journal:  Ther Drug Monit       Date:  1983-06       Impact factor: 3.681

View more
  5 in total

1.  Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; Nagireddy Putluri; Sridevi Devaraj; David Sheikh-Hamad; John M Vierling; John A Goss; Abbas Rana; Gagan K Sood; Prasun K Jalal; Lesley A Inker; Robert P Mohney; Hocine Tighiouart; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; William R Hutson; Charles D Howell; Jean-Pierre Raufman; Laurence S Magder; Cristian Coarfa
Journal:  Transl Res       Date:  2017-12-12       Impact factor: 7.012

Review 2.  Methods of Estimating Kidney Function for Drug Dosing in Special Populations.

Authors:  Laura A Hart; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

Review 3.  New Developments in Hepatorenal Syndrome.

Authors:  Ayse L Mindikoglu; Stephen C Pappas
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-07       Impact factor: 11.382

4.  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; William E Mitch; Laurence S Magder; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; Charles D Howell; Jean-Pierre Raufman; Abbas Rana; John A Goss; Saira A Khaderi; John M Vierling
Journal:  Dig Dis Sci       Date:  2018-02-01       Impact factor: 3.199

5.  Serum BTP concentrations are not affected by hepatic dysfunction.

Authors:  Debarati Chakraborty; Ayub Akbari; Greg A Knoll; Jennifer A Flemming; Catherine Lowe; Shareef Akbari; Christine A White
Journal:  BMC Nephrol       Date:  2018-04-13       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.